Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing-Reference-Cited by-同舟云学术

Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing

Published:2012-02 Issue:2 Volume:56 Page:374-380
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Björnsson Einar,Jacobsen Elin I.,Kalaitzakis Evangelos

Publisher

Elsevier BV

Subject

Hepatology

Reference39 articles.

1. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia;Bradford;Arch Intern Med,1999

2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Wright;Lancet,1994

3. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial;Schwartz;JAMA,2001

4. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group;Shepherd;N Engl J Med,1995

5. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver;Larrey;Semin Liver Dis,2002

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of statin therapy in kidney transplant recipients: a systematic review and meta-analysis;Lipids in Health and Disease;2024-09-11

2. Prescription patterns of statins in cirrhotic patients: a survey among primary care physicians and cardiologists;Baylor University Medical Center Proceedings;2024-07-08

3. Rare Clinically Significant Idiosyncratic Drug Induced Liver Injury Caused by Low Dose Atorvastatin: Time for a New Approach to Surveillance and Risk Identification;International Journal of Gastroenterology;2024-06-06

4. Transporter Genes and statin-induced Hepatotoxicity;Cardiovascular Drugs and Therapy;2024-05-29

5. Aldo-keto reductase-7A2 protects against atorvastatin-induced hepatotoxicity via Nrf2 activation;Chemico-Biological Interactions;2024-04